Bioprocess Bags Market Size & Share, by Type (2D, 3D); Workflow (Upstream Process, Downstream Process, Process Development); End-User (Pharmaceutical Companies, CMOs & CROs, Research Institutes); Product (Standard, Custom); Application (Buffer & Media Storage, Cell Culture, Cell Separation & Harvest, Chromatography Feed & Collection, Ultrafiltration & Diafiltration, Intermediate & Final Product Hold) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5343
  • Published Date: Oct 25, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Bioprocess Bags Market size is poised to reach USD 23 Billion by the end of 2036, growing at a CAGR of 19% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of bioprocess bags was USD 5 Billion. The reason behind the growth is impelled by the spiking manufacturing of vaccines. Pharmaceutical firms create and make use of bioprocess to develop, transport, are cultivate vaccines.

Lately, more than 1 billion doses of vaccine are produced globally each month, and the total vaccine production exceeded the global demand in 2022 to over 22 billion.

The growing popularity of single-use bioprocessing technologies are believed to fuel the bioprocess bags market. Owing to the quick uptake of disposable bioprocessing equipment by pharmaceutical firms, single-use technologies, or goods meant for one-time use, have acquired substantial popularity that can be employed throughout the bioproduction process, from the creation of buffers and media to the cultivation of vaccines in bioreactors.

/admin/upload_images/Bioprocess Bags Market.webp
Get more information on this report: Request Free Sample PDF

Bioprocess Bags Market: Key Insights

Base Year


Forecast Year




Base Year Market Size (2023)

~ USD 5 Billion

Forecast Year Market Size (2036)

~ USD 23 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Bioprocess Bags Market: Growth Drivers and Challenges


Growth Drivers

  • Surge in Drug Development– Single-use bioprocess bags utilize Foetal bovine serum (FBS) in bioprocessing which is a vital part of medication discovery and the production of biopharmaceuticals.
  • Growing Need for Biologics and Biosimilars- Bioprocess bags, which exist in a variety of sizes, are frequently used for the storage, transport, and processing of biologics and biosimilars owing to their sterile and adaptable qualities, as well as the lower danger of cross-contamination.
  • Extensive Usage in Media Storage & Preparation- Single-use bioprocessing bags are designed to handle a variety of processes such as media preparation & storage as they are a flexible and customizable solution for the safe handling of liquids.
  • Increasing Popularity of Personalized Medicine- Bioprocess bags have become a crucial part of the production of personalized medicine owing to their suitability and flexibility.
  • Rising Prevalence of Chronic Diseases- The demand for biological therapeutics is driven by the rising incidence of chronic diseases which may drive the demand for bioprocess bags owing to their sterile and adaptable qualities.
  • Surge in Outsourcing Activities by Contract Manufacturing Organizations (CMOs) - CMOs are always searching for improved single-use systems for their customers as a result many pharmaceutical and biotechnology firms are increasingly using these bioprocess bags.


  • Exorbitant Cost of Bioprocess Bags - The price of bioprocess bags depends on the configuration chosen and also involves expensive specialized materials including sterile polymers and complex multi-layer structures. Besides this, the stringent rules & regulations required can drive up the overall manufacturing costs of bioprocess bags.
  • Environmental Concerns Arising Out from The Usage of Single-Use System
  • Presence of Alternative Technologies Including Stainless Steel Containers.

Bioprocess Bags Segmentation

Type (2D Bioprocess Bags, 3D Bioprocess Bags)

The 2D bioprocess bags segment in the bioprocess bags market is estimated to gain a robust revenue share of 56% in the coming years owing to the rising prevalence of diabetes. Compared to high-income countries, prevalence has been increasing more quickly in low- and middle-income nations as a result of an increase in obesity, alcohol consumption, immigration, and urbanization brought on by a variety of factors which is a significant factor in kidney failure, heart attacks, strokes, blindness, and lower limb amputating.

Diabetes treatment frequently includes taking insulin or other diabetes medications or the use of an insulin pump, routine blood sugar monitoring, and carbohydrate tracking by frequently utilizing a variety of insulin kinds that differ in their rates of action and the duration of their effects as it takes the place of the hormone that your body is unable to make.

Moreover, 2D bioprocess bags are used for a wide range of uses including the preparation, storage, and transportation of biopharmaceutical solutions such as insulin and other diabetes-related solutions. By 2030, there will be more than 7070 new cases of type 2 diabetes worldwide for every 100,000 people.

Bioprocess bags market from the 3D bioprocess bags segment is anticipated to garner notable revenue share during the forecast timeframe. The 3D single-use bag comes in sizes ranging from 50L to 3.500L and has a completely inert polyethylene fluid contact layer created from different films that each have special qualities that are the perfect option for a variety of biopharmaceutical applications, including the preparation, storage, and transportation of biopharmaceutical solutions.

Workflow (Upstream Process, Downstream Process, Process Development)

The upstream process segment is expected to hold 44% share of the global bioprocess bags market during the forecast period. Cell cultures, medium, and other biopharmaceutical production materials are stored and transported using bioprocessing bags in upstream processing to reduce the danger of contamination and are essential for preserving the effectiveness and safety of biopharmaceutical products. Furthermore, the downstream process may gain a significant share as they provide a number of benefits, such as a lower risk of contamination, less cleaning and validation procedures.

End-User (Pharmaceutical & Biopharmaceutical Companies, CMOs & CROs, Academic & Research Institutes)

The pharmaceutical & biopharmaceutical companies segment is poised to account for 47% of the global bioprocess bags market share by 2036, due to the rising introduction of new products. For instance, in February 2021, Saint-Gobain Life Sciences, a pioneer in the production of innovative, high-performance polymer solutions launched a new cell VueLife "HP" Series Bag cell culture testing culture bag designed specifically for T cell-derived therapies with a unique laminate film layer for treating cancer by harnessing the patient’s immune system by isolating their T cells and engineering them to elicit an immune response.

Our in-depth analysis of the global bioprocess bags market includes the following segments:


  • 2D Bioprocess Bags
  • 3D Bioprocess Bags


  • Upstream Process
  • Downstream Process
  •  Process Development


  • Buffer & Media Storage
  • Cell Culture
  • Cell Separation & Harvest
  • Chromatography Feed & Collection
  • Ultrafiltration & Diafiltration
  • Intermediate & Final Product Hold


  • Pharmaceutical & Biopharmaceutical Companies
  • CMOs & CROs
  •  Academic & Research Institutes


  • Standard Bioprocess Bags
  •  Custom Bioprocess Bags


  • Small
  • Medium
  •  Large
  • Extra Large

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Bioprocess Bags Industry - Regional Synopsis

North American Market Forecast

Bioprocess bags market in North America is predicted to account for the largest share of 36% by 2036 impelled by the rising funding in the manufacturing of vaccines. As a result, there has been an increase in the development of vaccines in the region which would lead to higher demand for bioprocess bags. For instance, As of April 2020, American biopharmaceutical companies worked on around 240 vaccines to prevent and treat diseases such as cancer, Alzheimer's disease, allergies, and autoimmune disorders by employing new technologies that have the potential to stop the spread of human immunodeficiency virus (HIV), provide protection against malaria, and treat various types of cancer. In 2020 through March 2022, the US federal government spent over USD 2 billion on research and development of the mRNA COVID-19 vaccines.

APAC Market Statistics

The APAC bioprocess bags market is estimated to be the second largest, during the forecast timeframe led by rapidly rising population. It is expected that a high birth rate, rapid industrialization and the expansion of opportunity in cities, lack of education, illiteracy, inadequate sex education knowledge, rituals, and superstition are the important factors in population growth in countries such as India, and China. These factors have led to increasing demand for various biopharmaceutical products including vaccines, drugs, and other related products. As a consequence, a huge demand for bioprocess bags can be witnessed in the region by the year 2036. According to estimates, the population of India is expected to reach over 1 billion by 2030.

Research Nester
/admin/upload_images/Bioprocess Bags Market size.webp
Get more information on this report: Request Free Sample PDF

Companies Dominating the Bioprocess Bags Market

    • Thermo Fisher Scientific Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Sartorius AG
    • Danaher Corporation
    • Merck KGaA
    • CellBios Healthcare And Lifesciences Pvt Ltd.
    • Saint-Gobain
    • Corning Incorporated
    • Entegris
    • Meissner Filtration Products, Inc.
    • PROAnalytics, LLC
    • Sartorius Stedim Biotech


In The News

  • Thermo Fisher Scientific Inc. Announced to establish a production facility for single-use technology (SUT) that can be utilized in numerous manufacturing processes, including processing, separation, and storage, owing to their flexibility, which enables expandable bioreactor quantities and a more environmentally friendly procedure than stainless steel reactors.
  • Sartorius Stedim Biotech acquired Polyplus a provider of innovative upstream technologies to make reagents and plasmids that are vitally important for creating viral vectors that are used in cell and gene treatment therapies more cheaply, to enable the workflow of the entire process to be optimized and effectively grow its product line and implement an effective acquisition strategy.

Author Credits:  Smruti Ranjan, Rajrani Baghel

  • Report ID: 5343
  • Published Date: Oct 25, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Spiking manufacturing of vaccines and the growing popularity of single-use bioprocessing technologies are the major factors driving the growth of the market.

The market size of bioprocess bags is anticipated to attain a CAGR of 19% over the forecast period, i.e., 2024-2036.

The major players in the market are Sartorius AG, Danaher Corporation, Merck KGaA, CellBios Healthcare And Lifesciences Pvt Ltd., Saint-Gobain, Corning Incorporated, Entegris, Meissner Filtration Products, Inc., PROAnalytics, LLC.

The 2D bioprocess segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Bioprocess Bags Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying